Benefit-cost analysis of residential and outpatient addiction treatment in the state of Washington

Evaluation Review

Volumn 24, Issue 6, 2000, Pages 609-633

  French, Michael T ^a   Salomé, Helena J ^a   Krupski, Antoinette ^a   McKay, James R ^a   Donovan, Dennis M ^a   McLellan, A Thomas ^a   Durell, Jack ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; AMBULATORY CARE; ARTICLE; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; DRUG DEPENDENCE TREATMENT; ECONOMICS; FEMALE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT; RESIDENTIAL HOME; UNITED STATES;

AMBULATORY CARE; COST-BENEFIT ANALYSIS; FEMALE; HEALTH CARE COSTS; HUMANS; LENGTH OF STAY; MALE; OUTCOME ASSESSMENT (HEALTH CARE); RESIDENTIAL FACILITIES; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE TREATMENT CENTERS; SUBSTANCE-RELATED DISORDERS; WASHINGTON;

EID: 0034565765     PISSN: 0193841X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0193841x0002400603     Document Type: Article

References (57)

1. American Hospital Association. 2000. Hospital statistics. Chicago: American Hospital Association.
2. American Medical Association. 1999. Physicians fee schedule for Washington-Medicare. Chicago: American Medical Association.
3. American Society of Addiction Medicine. 1996. Patient placement criteria for the treatment of substance-related disorders (2d ed.). Chevy Chase, MD: American Society of Addiction Medicine. ASAM PPC-II.
4. Anderson, D. W., B. J. Bowland, W. S. Cartwright, and G. Bassin. 1998. Service-level costing of drug abuse treatment. Journal of Substance Abuse Treatment 15:201-11.
5. Annis, H. M. 1985-1986. Is inpatient rehabilitation of the alcoholic cost effective? Con position. Advances in Alcohol and Substance Abuse 5:175-90.
6. Ball, J. C., and A. Ross. 1991. The effectiveness of methadone maintenance treatment. Patients, programs, services, and outcome. New York: Springer-Verlag.
7. Budde, D., B. Rounsaville, and K. Bryant. 1992. Inpatient and outpatient cocaine abusers: Clinical comparisons at intake and one-year follow-up. Journal of Substance Abuse Treatment 9:337-42.
8. Cartwright, W. S. 1998. Cost-benefit and cost-effectiveness analysis of drug abuse treatment services. Evaluation Review 22:609-36.
9. Cohen, M. A. 1998. The monetary value of saving a high risk youth. Journal of Quantitative Criminology 14 (1): 5-33.
10. Craig, R. J., R. Olson, and G. Shalton. 1990. Improvement in psychological functioning among drug abusers: Inpatient treatment compared to outpatient methadone maintenance. Journal of Substance Abuse Treatment 7:11-9.
11. Drummond, M. F., C. P. O'Brien, G. L. Stoddart, and G. W. Torrance. 1997. Methods for the economic evaluation of health care programmes. New York: Oxford University Press.
12. Finney, J. W., and R. H. Moos. 1996. The effectiveness of inpatient and outpatient treatment for alcohol abuse: Effect sizes, research design issues and explanatory mechanisms. Addiction 91:1813.
13. French, M. T. 1995. Economic evaluation of drug abuse treatment programs: Methodology and findings. American Journal of Drug and Alcohol Abuse 21:111-35.
14. _. 2000. Economic evaluation of alcohol treatment services. Evaluation and Program Planning 23:27-39.
15. French, M. T., L. J. Dunlap, G. A. Zarkin, K. A. McGeary, and A. T. McLellan. 1997. A structured instrument for estimating the economic cost of drug abuse treatment. The drug abuse treatment cost analysis program (DATCAP). Journal of Substance Abuse Treatment 14:1-11.
16. French, M. T., J. E. Mauskopf, J. L. Teague, and E. J. Roland. 1996. Estimating the dollar value of health outcomes from drug-abuse interventions. Medical Care 34:890-910.
17. French, M. T., K. E. McCollister, J. Cacciola, A. T. McLellan, and J. Durell. 2000. Benefit-cost analysis of addiction treatment in Arkansas: Comparison of specialty and standard residential programs for pregnant and parenting women. University of Miami, Coral Gables. Unpublished manuscript.
18. French, M. T., K. E. McCollister, S. Sacks, K. McKendrick, and G. De Leon. 2000. Benefit-cost analysis of a modified therapeutic community for mentally ill chemical abusers. University of Miami, Coral Gables. Unpublished manuscript.
19. French, M. T., and K. A. McGeary. 1997. Estimating the economic cost of substance abuse treatment. Health Economics 6:539-44.
20. French, M. T., H. J. Salomé, J. L. Sindelar, and A. T. McLellan. 2000. Benefit-cost analysis of substance abuse treatment: Methodological guidelines and application using the DATCAP and ASI. University of Miami, Coral Gables. Manuscript submitted for publication.
21. Gerstein, D. R., R. A. Johnson, H. Harwood, K. Fountain, N. Suter, and K. Malloy. 1994. Evaluating recovery services: The California Drug and Alcohol Treatment Assessment (CALDATA). General report. Sacramento: California Department of Alcohol and Drug Program.
22. Gold, M. R., J. E. Siegel, L. B. Russell, and M. C. Weinstein. 1996. Cost-effectiveness in health and medicine. New York: Oxford University Press.
23. Goodman, A. C., H. D. Holder, E. Nishiura, and J. R. Hankin. 1992. An analysis of short-term alcoholism treatment cost functions. Medical Care 30:795-810.
24. Goodman, A. C., E. Nishiura, and J. R. Hankin. 1998. Short-term drug abuse treatment costs and utilization. A multi-employer analysis. Medical Care 36:1214-27.
25. Goodman, A. C., E. Nishiura, J. R. Hankin, H. D. Holder, and J. M. Tilford. 1996. Long-term alcoholism treatment costs. Medical Care Research and Review 53:441-64.
26. Harwood, H., D. Fountain, and G. Livermore. 1998. The economic costs of alcohol and drug abuse in the United States, 1992 (98-4327). Rockville, CT: National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism.
27. Harwood, H. J., R. L. Hubbard, J. Collins, and J. V. Rachal. 1995. A cost-benefit analysis of drug abuse treatment. Research in Law and Policy Studies 3:191-214.
28. Hayashida, M., A. I. Alterman, A. T. McLellan, C. P. O'Brien, J. J. Purtill, J. R. Volpicelli, A. H. Raphaelson, and C. P. Hall. 1989. Comparative effectiveness and costs of inpatient and outpatient detoxification of patients with mild-to-moderate alcohol withdrawal syndrome. New England Journal of Medicine 320:358-65.
29. Holder, H. D., and J. O. Blose. 1986. Alcoholism treatment and total health care utilization and costs: A four year longitudinal analysis of federal employees. Journal of the American Medical Association 256:1456-60.
30. _. 1992. The reduction of healthcare costs associated with alcoholism treatment: A 14-year longitudinal study. Journal of Studies on Alcohol 53:293-302.
31. Holder, H. D., R. A. Cisler, R. Longabaugh, R. L. Stout, A. J. Treno, and A. Zweben. 2000. Alcoholism treatment and medical care costs from Project MATCH. Addiction 95(7): 999-1013.
32. Holder, H. D., and R. D. Shachtman. 1987. Estimating health care savings associated with alcoholism treatment. Alcoholism, Clinical and Experimental Research 11:66-13.
33. Institute of Medicine (IOM). 1990. In Treating drug problems: A study of the evolution, effectiveness, and financing of public and private drug treatment systems, edited by D. Gustein and H. Harwood. Washington, DC: National Academy Press.
34. Johanneson, M. 1996. Theory and methods of economic evaluation of health care. Dordrecht, Netherlands: Kluwer Academic.
35. Kenkel, D. 1997. On valuing morbidity, cost-effectiveness analysis, and being rude. Journal of Health Economics 16:749-57.
36. Lave, L. B., and S. V. Joshi. 1996. Benefit-cost analysis in public health. Annual Review of Public Health 17:203-19.
37. McKay, J. R., J. S. Cacciola, A. T. McLellan, A. I. Alterman, and P. W. Wirtz. 1997. An initial evaluation of the psychosocial dimensions of the American Society of Addiction Medicine criteria for inpatient versus intensive outpatient substance abuse rehabilitation. Journal of Studies on Alcohol 58:239-52.
38. McKay, J. R., D. M. Donovan, A. T. McLellan, A. Krupski, M. Hansten, K. Geary, and J. Cecere. 2000. Evaluation of full vs. partial continuum of care in the treatment of publicly-funded substance abusers. Washington State TOPPS I project (final report). Submitted by the Washington State Department of Social and Health Services, Division of Alcohol and Substance Abuse, to the Center for Substance Abuse Treatment in partial fulfillment of Contract No 270-97-7020.
39. McKay, J. R., and A. T. McLellan. 1998. Deciding where to start: Working with polyproblem individuals. In Treating addictive behaviors: Applied clinical psychology, editedby W. R. Miller and N. Heather (2d ed., pp. 173-86). New York: Plenum Press.
40. McLellan, A. T. 1980. An improved diagnostic evaluation instrument for substance abuse patients. Journal of Nervous and Mental Disease 168:26-33.
41. McLellan, A. T., H. Kushner, D. Metzger, R. Peters, I. Smith, G. Grissom, H. Pettinati, and M. Argeriou. 1992. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment 9:199-213.
42. Miller, W. R., and R. K. Hester. 1986. Inpatient alcoholism treatment. Who benefits? American Psychologist 41:794-805.
43. Plotnick, R. D. 1994. Applying benefit-cost analysis to substance use prevention programs. International Journal of Addiction 29:339-59.
44. Rajkumar, A. S., and M. T. French. 1997. Drug abuse, crime costs, and the economic benefits of treatment. Journal of Quantitative Criminology 13:291-323.
45. Rosser, R., and P. Kind. 1978. A scale of valuations for status of illness: Is there a social consensus? International Journal of Epidemiology 7:347-58.
46. Rouse, B., N. Kozel, and L. Richards. (Eds.). 1985. Self-report methods of estimating drug use: Meeting current challenges to validity. Rockville, MD: National Institute on Drug Abuse.
47. Rundell, O. H., and A. Paredes. 1979. Benefit-cost methodology in the evaluation of therapeutic services for alcoholism. Alcoholism: Clinical and Experimental Research 3:324-31.
48. Salomé, H. J., and M. T. French. (Forthcoming). Using cost and financing instruments in the economic evaluation of substance abuse treatment services. Recent developments in alcoholism. Services research in the managed care era, edited by M. Galanter. New York: Plenum.
49. Sindelar, J. L., M. Jofre-Bonet, M. T. French, and A. T. McLellan. 1999. Cost-effectiveness analysis of treatment for illicit drug dependence: Paradoxes with multivariate outcomes. Unpublished manuscript, Yale University, New Haven, CT.
50. Sindelar, J. L., and W. G. Manning. 1997. Treating drug abusers effectively. In Cost-benefit and cost-effectiveness analysis: Issues in the evaluation of the treatment of illicit drug abuse, edited by J. A. Egertson, D. M. Fox, and A. I. Leshner. Malden, UK: Blackwell.
51. StataCorp. (1999). Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation.
52. Swint, M. J., and W. B. Nelson. 1977. Prospective evaluation of alcoholism rehabilitation efforts: The role of cost-benefit and cost-effectiveness analyses. Journal of Studies on Alcohol 38:1386-404.
53. Tabbush, V. 1986. The effectiveness and efficiency of publicly funded drug abuse treatment and prevention programs in California: A benefit-cost analysis. Berkeley: University of California Press.
54. Tolley, G., D. Kenkel, and R. Fabian. 1994. Valuing health for policy: An economic approach. Chicago: The University of Chicago Press.
55. Turner, C., J. Lessler, and J. Devore. 1992. Effects of mode of administration and wording on reporting of drug use. In Survey measurement of drug use: Methodological studies. National Institute on Drug Abuse.
56. Yin, D., and H. P. Forman. 1995. Health-care and cost-benefit and cost-effectiveness analysis: An overview. Journal of Vascular and Interventional Radiology 6:311-20.
57. Zarkin, G. A., M. T. French, D. W. Anderson, and C. J. Bradley. 1994. A conceptual framework for the economic evaluation of substance abuse interventions. Evaluation and Program Planning 17:409-18.